JPWO2020006617A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020006617A5 JPWO2020006617A5 JP2021522113A JP2021522113A JPWO2020006617A5 JP WO2020006617 A5 JPWO2020006617 A5 JP WO2020006617A5 JP 2021522113 A JP2021522113 A JP 2021522113A JP 2021522113 A JP2021522113 A JP 2021522113A JP WO2020006617 A5 JPWO2020006617 A5 JP WO2020006617A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- ala
- trp
- tyr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694162P | 2018-07-05 | 2018-07-05 | |
| US62/694,162 | 2018-07-05 | ||
| US16/502,215 US10905738B2 (en) | 2018-07-05 | 2019-07-03 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
| US16/502,215 | 2019-07-03 | ||
| PCT/BR2019/050249 WO2020006617A1 (en) | 2018-07-05 | 2019-07-04 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021530562A JP2021530562A (ja) | 2021-11-11 |
| JP2021530562A5 JP2021530562A5 (https=) | 2022-06-24 |
| JPWO2020006617A5 true JPWO2020006617A5 (https=) | 2022-06-24 |
| JP7317956B2 JP7317956B2 (ja) | 2023-07-31 |
Family
ID=69059636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522113A Active JP7317956B2 (ja) | 2018-07-05 | 2019-07-04 | 合成ペプチド、プロドラッグ、医薬組成物および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10905738B2 (https=) |
| EP (1) | EP3818070B1 (https=) |
| JP (1) | JP7317956B2 (https=) |
| KR (1) | KR20210029161A (https=) |
| CN (1) | CN112654634B (https=) |
| BR (1) | BR112021000105A2 (https=) |
| CA (1) | CA3104183A1 (https=) |
| WO (1) | WO2020006617A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026507422A (ja) * | 2023-02-17 | 2026-03-04 | バイオゼウス バイオファーマシューティカル エス．エー． | 性機能障害の治療のための局所用ペプチド製剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| AT387234B (de) | 1987-03-05 | 1988-12-27 | Vogelbusch Gmbh | Vorrichtung zur zuechtung von dauerformen insbesondere filamentoeser mikroorganismen |
| US5470949A (en) | 1992-12-15 | 1995-11-28 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for making amino acid glycosides and glycopeptides |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| US20030082671A1 (en) | 2001-07-24 | 2003-05-01 | Thomas Hoeg-Jensen | Method for making acylated polypeptides |
| US7585523B2 (en) | 2002-08-27 | 2009-09-08 | Targeted Medical Pharma | Composition and method to augment and sustain neurotransmitter production |
| CA2560956A1 (en) | 2004-03-29 | 2005-10-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Amphipathic glycopeptides |
| CN101563102B (zh) | 2006-09-22 | 2014-12-17 | 德克萨斯系统大学董事会 | 治疗内皮功能障碍的方法 |
| KR20090115852A (ko) | 2007-01-19 | 2009-11-09 | 카이 파마슈티컬즈 | 안정성 및 전달 효율을 증가시키기 위한 펩타이드 조성물의 변형 |
| BRPI0800596A2 (pt) | 2008-01-31 | 2009-09-22 | Univ Minas Gerais | método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer |
| CN101585872A (zh) | 2008-05-23 | 2009-11-25 | 成都蓉药集团四川长威制药有限公司 | 重组蛛毒蛋白、其制备方法和表达载体以及用于治疗ed的药物 |
| KR20130139254A (ko) | 2010-11-09 | 2013-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부 침투 및 세포 진입（ｓｐａｃｅ） 펩타이드 및 그의 사용방법 |
| PT2899198T (pt) * | 2012-08-20 | 2018-06-29 | Univ Federal De Minas Gerais Ufmg | Péptido sintético pntx(19), composições farmacêuticas e utilização |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| WO2015162195A1 (en) | 2014-04-23 | 2015-10-29 | Novo Nordisk A/S | Fatty acid acylated amino acids for oral peptide delivery |
| WO2017068388A2 (pt) | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
| KR101613302B1 (ko) | 2015-12-30 | 2016-04-18 | (주)넥스젠바이오텍 | Sv82 폴리펩타이드 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
| KR101636851B1 (ko) | 2016-06-03 | 2016-07-06 | (주)넥스젠바이오텍 | 피부 세포 증식 효과가 증가한 열 안정성 인간 상피세포성장인자-거미독 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
-
2019
- 2019-07-03 US US16/502,215 patent/US10905738B2/en active Active
- 2019-07-04 BR BR112021000105-0A patent/BR112021000105A2/pt unknown
- 2019-07-04 CN CN201980057994.1A patent/CN112654634B/zh active Active
- 2019-07-04 KR KR1020207037684A patent/KR20210029161A/ko active Pending
- 2019-07-04 EP EP19830422.2A patent/EP3818070B1/en active Active
- 2019-07-04 CA CA3104183A patent/CA3104183A1/en active Pending
- 2019-07-04 WO PCT/BR2019/050249 patent/WO2020006617A1/en not_active Ceased
- 2019-07-04 JP JP2021522113A patent/JP7317956B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0651765B1 (en) | Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis | |
| AU662508B2 (en) | Fusion polypeptides | |
| CN115768460A (zh) | 长效glp-1/gip双重激动剂 | |
| TWI388333B (zh) | 具有改良性質之重組表面張力素 | |
| JP2006514607A5 (https=) | ||
| JP2602968B2 (ja) | 肺胞の界面活性タンパク類 | |
| JP2008534628A (ja) | ペプチド誘導体の製造のための方法 | |
| TW200817432A (en) | Amidated insulin glargine | |
| WO2014052451A2 (en) | Insulin analog dimers | |
| JP2018508504A (ja) | 持続型インスリンまたはインスリンアナログ結合体 | |
| KR20120062777A (ko) | 변형된 혈관활성 장 펩티드 | |
| JP2026032056A5 (https=) | ||
| JPH06228199A (ja) | 血液脳関門通過可能なペプチド結合体 | |
| AU2018205458A1 (en) | PAC1 receptor agonists (MAXCAPS) and uses thereof | |
| JP2005053929A (ja) | 肺胞界面活性タンパク質 | |
| JP2021516222A5 (https=) | ||
| JP2021530562A5 (https=) | ||
| WO2009018908A1 (en) | Synthetic pulmonary surfactant peptides | |
| JPWO2020006617A5 (https=) | ||
| JPH01501391A (ja) | 新規ペプチド | |
| JP4850321B2 (ja) | アンギオテンシン誘導体 | |
| JPH01131197A (ja) | Ａｎｆ活性を有するペプチド類 | |
| JPH06220090A (ja) | ポリペプチド | |
| JP2778249B2 (ja) | 新規生理活性ペプチド類および該ペプチド類を有効成分とするカルシウム代謝調整剤 | |
| EP0367463A1 (en) | Calcitonin gene related peptide analogues |